Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 Jul 17;11(14):4900-4909.
doi: 10.18632/aging.102083.

Osteoprotegerin as a biomarker of geriatric frailty syndrome

Affiliations
Observational Study

Osteoprotegerin as a biomarker of geriatric frailty syndrome

Alessia Valentini et al. Aging (Albany NY). .

Abstract

The lack of a univocal definition of frailty, a condition frequently found in the elderly population which is correlated with an increased risk of mortality, has prompted the search for clinical and laboratory parameters associated with this condition. Whereas OPG is a protein involved in different pathophysiological conditions including bone, vascular, immune and tumor disease and studies found a positive linear correlation between OPG and age we hypothesized that it may represent a frailty marker in the elderly.We conducted an observational study of 172 elderly subjects, with and without hip fracture, including a multidimensional geriatric evaluation and a laboratory evaluation, aimed to evaluate the association between OPG and frailty.Frailty Score was associated with FT3 and osteoprotegerin (OPG), regardless of fracture event. Excluding subjects with hip fracture, in whom the acute event had a direct effect on bone production of OPG, the Frailty Score showed a linear correlation with circulating levels of osteoprotegerin.In the elderly, an increase in osteoprotegerin levels may reflect a progressive accumulation of organ damage leading to the development of frailty. The correlation between OPG and Frailty Score found in our study points to its potential use as a biomarker for geriatric frailty syndrome.

Keywords: OPG; aging; biomarkers; frailty; geriatric assessment.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
The relationship between OPG and frailty.
Figure 2
Figure 2
The relationship between OPG and frailty in subjects without fracture (A) and in patients with hip fracture (B).
Figure 3
Figure 3
The relationship between OPG and frailty obtained excluding non-frail subjects.
Figure 4
Figure 4
The relationship between OPG and FT3.

References

    1. Sander M, Oxlund B, Jespersen A, Krasnik A, Mortensen EL, Westendorp RG, Rasmussen LJ. The challenges of human population ageing. Age Ageing. 2015; 44:185–87. 10.1093/ageing/afu189 - DOI - PMC - PubMed
    1. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009; 374:1196–208. 10.1016/S0140-6736(09)61460-4 - DOI - PMC - PubMed
    1. Fulop T, Larbi A, Witkowski JM, McElhaney J, Loeb M, Mitnitski A, Pawelec G. Aging, frailty and age-related diseases. Biogerontology. 2010; 11:547–63. 10.1007/s10522-010-9287-2 - DOI - PubMed
    1. Lang PO, Michel JP, Zekry D. Frailty syndrome: a transitional state in a dynamic process. Gerontology. 2009; 55:539–49. 10.1159/000211949 - DOI - PubMed
    1. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013; 381:752–62. 10.1016/S0140-6736(12)62167-9 - DOI - PMC - PubMed

Publication types

LinkOut - more resources